Pharmaceutical Regulatory Affairs plays a pivotal role in ensuring the safety, efficacy, and quality of pharmaceutical products, acting as the liaison between pharmaceutical companies and regulatory authorities. This dynamic field navigates the complex landscape of regulations and guidelines, shaping the development, manufacturing, and marketing of drugs.
Professionals in Regulatory Affairs are responsible for interpreting and implementing regulatory requirements to ensure compliance throughout the drug development lifecycle. They work closely with cross-functional teams to strategize and execute regulatory submissions, seeking approvals from health authorities such as the FDA, EMA, and other regulatory bodies worldwide.
The regulatory landscape is ever-evolving, and Regulatory Affairs professionals stay abreast of changes, guiding companies through the intricacies of new guidelines and ensuring adherence to established standards. They contribute to the successful launch and post-marketing surveillance of pharmaceutical products, addressing challenges related to labeling, safety reporting, and product recalls.
Pharmaceutical Regulatory Affairs professionals also play a crucial role in fostering international harmonization, facilitating global drug development and access. Their expertise is instrumental in navigating the complex web of regulations, ultimately contributing to the availability of safe and effective medicines for patients worldwide.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia